StockData
Hepion Pharmaceuticals, Inc. logo

Hepion Pharmaceuticals, Inc. (HEPA) stock

HEPAOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as CTRVP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 17, 2026Score 1/30
$0.10−0.00 (-1.45%)

Close on Oct 19, 2026Market cap $7.26MP/E –Yield –

Hepion Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Hepion Pharmaceuticals's operating cash flow for the twelve months ending Sep 30, 2026 was -$2.03M. For fiscal 2025 it was -$3.27M. The highest annual figure on record is -$1.36M in fiscal 2014.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$3.27M–
FY2024Dec 31, 2024-$18.22M–
FY2023Dec 31, 2023-$40.89M–
FY2022Dec 31, 2022-$34.96M–
FY2021Dec 31, 2021-$31.22M–
FY2020Dec 31, 2020-$16.17M–
FY2019Dec 31, 2019-$7.57M–
FY2017Jun 30, 2017-$19.17M–
FY2016Jun 30, 2016-$16.56M–
FY2015Jun 30, 2015-$9.67M–
FY2014Jun 30, 2014-$1.36M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ3 2026Sep 30, 2026-$881.90K–
Q2 FY2026CQ2 2026Jun 30, 2026-$1.39M–
Q1 FY2026CQ1 2026Mar 31, 2026$578.58K–
Q4 FY2025CQ4 2025Dec 31, 2025-$332.78K–
Q3 FY2025CQ3 2025Sep 30, 2025-$445.96K–
Q2 FY2025CQ2 2025Jun 30, 2025-$1.38M–
Q1 FY2025CQ1 2025Mar 31, 2025-$1.12M–
Q4 FY2024CQ4 2024Dec 31, 2024-$1.15M–
Q3 FY2024CQ3 2024Sep 30, 2024-$2.52M–
Q2 FY2024CQ2 2024Jun 30, 2024-$10.93M–
Q1 FY2024CQ1 2024Mar 31, 2024-$3.62M–
Q4 FY2023CQ4 2023Dec 31, 2023-$9.00M–
Q3 FY2023CQ3 2023Sep 30, 2023-$11.24M–
Q2 FY2023CQ2 2023Jun 30, 2023-$12.44M–
Q1 FY2023CQ1 2023Mar 31, 2023-$8.21M–
Q4 FY2022CQ4 2022Dec 31, 2022-$4.80M–
Q3 FY2022CQ3 2022Sep 30, 2022-$12.53M–
Q2 FY2022CQ2 2022Jun 30, 2022-$7.50M–
Q1 FY2022CQ1 2022Mar 31, 2022-$10.13M–
Q4 FY2021CQ4 2021Dec 31, 2021-$7.38M–
Q3 FY2021CQ3 2021Sep 30, 2021-$11.32M–
Q2 FY2021CQ2 2021Jun 30, 2021-$5.17M–
Q1 FY2021CQ1 2021Mar 31, 2021-$7.35M–
Q4 FY2020CQ4 2020Dec 31, 2020-$4.53M–
Q3 FY2020CQ3 2020Sep 30, 2020-$3.85M–
Q2 FY2020CQ2 2020Jun 30, 2020-$3.11M–
Q1 FY2020CQ1 2020Mar 31, 2020-$4.68M–
Q4 FY2019CQ4 2019Dec 31, 2019-$2.44M–
Q3 FY2019CQ3 2019Sep 30, 2019-$1.80M–
Q2 FY2019CQ2 2019Jun 30, 2019-$1.26M–
Q1 FY2019CQ1 2019Mar 31, 2019-$2.06M–
Q4 FY2017CQ2 2017Jun 30, 2017-$4.25M–
Q3 FY2017CQ1 2017Mar 31, 2017-$5.22M–
Q2 FY2017CQ4 2016Dec 31, 2016-$5.34M–
Q1 FY2017CQ3 2016Sep 30, 2016-$4.38M–
Q4 FY2016CQ2 2016Jun 30, 2016-$4.40M–
Q3 FY2016CQ1 2016Mar 31, 2016-$3.88M–
Q2 FY2016CQ4 2015Dec 31, 2015-$5.48M–
Q1 FY2016CQ3 2015Sep 30, 2015-$2.80M–
Q4 FY2015CQ2 2015Jun 30, 2015-$4.34M–

More Hepion Pharmaceuticals figures

See a number that looks wrong?